This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, Assitance Publique Hopitaux, Inria Institut National De Recherche En Informatique Et En Automatique. Active years: 2020-2024.
Company Filing History:
1 out of 331 
1 out of 1 
1 out of 97 
Years Active: 2020-2024
Title: The Innovative Mind of Arthur Le Gall: A Visionary Inventor from Paris
Introduction:
Arthur Le Gall, a brilliant inventor from Paris, FR, has made significant contributions to the field of healthcare with his groundbreaking innovations. With two patents to his name, he has revolutionized cardiac devices and methods for evaluating ventriculo-aortic coupling in at-risk patients.
Latest Patents:
1. Cardiac device: Arthur Le Gall's cardiac device integrates a memory system for haemodynamic data and a computer for applying a complex cardiovascular model. This innovation extracts essential cardiac activity indicators, enhancing patient monitoring and care.
2. Method for continuous evaluation of ventriculo-aortic coupling: Le Gall's method focuses on monitoring ventriculo-aortic coupling in at-risk patients by analyzing pressure-flow loops. This novel approach offers vital insights for cardiovascular resuscitation.
Career Highlights:
Having worked at Assistance Publique—Hôpitaux de Paris and Université Paris Diderot—Paris 7, Arthur Le Gall has honed his skills and expertise in the medical field. His commitment to innovation has led to transformative advancements in cardiovascular healthcare.
Collaborations:
Le Gall has collaborated with esteemed professionals in his field, including Fabrice Vallée and Alexandre Mebazza. Together, they have shared knowledge, ideas, and passion for improving patient outcomes through cutting-edge technologies.
Conclusion:
Arthur Le Gall's unwavering dedication to innovation has positioned him as a trailblazer in the healthcare industry. His inventive spirit and collaboration with experts reflect his commitment to advancing medical technology for the benefit of at-risk patients worldwide.